TGFB1 and carcinoma: Next, we investigated whether the immune suppressive molecules PGE2, TGF-β, IDO, and PD-L1/L2, that previously have been described to be expressed by carcinoma fibroblasts (23–25), were involved in pancreatic CAF-mediated suppression.